About this release

This report provides supplementary information that was used to inform the higher-level conclusions and recommendations contained in the National benchmarking report on implementation of the Medication Assisted Treatment (MAT) standards 2021–22, which was published in June 2022.

Main points

Medication Assisted Treatment standards 1 to 5 were assessed across all 29 alcohol and drug partnerships (ADPs) areas. Of 145 standards of care assessed, 17% (25/145) are fully implemented, 65% (94/145) are partially implemented and 18% (26/145) are not implemented. This indicates that work has started or is well established in most ADP areas but that there is still a lot to do for full, consistent and sustained implementation of the standards across Scotland.

Chart: Red, Amber, Green, Blue (RAGB) score for all ADP areas for each MAT standard 1 to 5

Background

The term 'medication assisted treatment' (MAT) refers to the use of medication, such as opioids, together with psychological and social support, in the treatment and care of people who experience problems with their drug use. The Drug Deaths Taskforce published ten standards of care for MAT in May 2021. The MAT standards aim to improve access, choice and care for people affected by problematic substance use across Scotland.

General enquiries

If you have an enquiry relating to this publication, please email phs.mist@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Older versions of this publication

Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.

Last updated: 29 July 2022
Was this page helpful?